In This Article:
As global markets navigate through varied economic signals, Hong Kong's stock market has shown resilience, with the Hang Seng Index recently marking a notable uptick. In this context, understanding the appeal of dividend stocks becomes particularly pertinent for investors looking for potential stability and steady returns amidst fluctuating market conditions.
Top 10 Dividend Stocks In Hong Kong
Name | Dividend Yield | Dividend Rating |
China Construction Bank (SEHK:939) | 7.77% | ★★★★★★ |
Chongqing Rural Commercial Bank (SEHK:3618) | 8.51% | ★★★★★★ |
CITIC Telecom International Holdings (SEHK:1883) | 8.97% | ★★★★★★ |
Consun Pharmaceutical Group (SEHK:1681) | 8.35% | ★★★★★☆ |
S.A.S. Dragon Holdings (SEHK:1184) | 9.00% | ★★★★★☆ |
Bank of China (SEHK:3988) | 6.92% | ★★★★★☆ |
China Mobile (SEHK:941) | 6.51% | ★★★★★☆ |
Sinopharm Group (SEHK:1099) | 3.92% | ★★★★★☆ |
China Overseas Grand Oceans Group (SEHK:81) | 8.47% | ★★★★★☆ |
International Housewares Retail (SEHK:1373) | 8.55% | ★★★★★☆ |
Click here to see the full list of 84 stocks from our Top Dividend Stocks screener.
Let's explore several standout options from the results in the screener.
Sinopharm Group
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Sinopharm Group Co. Ltd., operating in the People's Republic of China, focuses on the wholesale and retail of pharmaceuticals, medical devices, and healthcare products, with a market capitalization of approximately HK$70.37 billion.
Operations: Sinopharm Group Co. Ltd. generates its revenue primarily through the sale of pharmaceuticals, medical devices, and healthcare products.
Dividend Yield: 3.9%
Sinopharm Group Co. Ltd. reported a slight decline in net income to CNY 1,420.14 million in Q1 2024 from CNY 1,590.34 million a year earlier, despite a sales increase to CNY 147,265.8 million from CNY 145,517.77 million. The company's dividends appear sustainable with a low cash payout ratio of 31.8% and have been stable over the past decade; however, its dividend yield of 3.92% is relatively low compared to top Hong Kong dividend payers at 7.52%. Sinopharm proposed a final dividend of RMB 0.87 per share for FY2023.
Consun Pharmaceutical Group
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Consun Pharmaceutical Group Limited, operating in the People's Republic of China, focuses on researching, developing, manufacturing, and selling Chinese medicines and medical contrast medium products with a market capitalization of approximately HK$5.72 billion.